Atjaunināt sīkdatņu piekrišanu

Practitioner's Guide to the Pct [Mīkstie vāki]

3.00/5 (2 ratings by Goodreads)
, ,
  • Formāts: Paperback / softback, 296 pages, height x width x depth: 231x156x15 mm, weight: 408 g
  • Izdošanas datums: 16-Feb-2015
  • Izdevniecība: American Bar Association
  • ISBN-10: 1627220143
  • ISBN-13: 9781627220149
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 156,58 €*
  • * Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena
  • Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena.
  • Daudzums:
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
Practitioner's Guide to the PctPalielināt
  • Formāts: Paperback / softback, 296 pages, height x width x depth: 231x156x15 mm, weight: 408 g
  • Izdošanas datums: 16-Feb-2015
  • Izdevniecība: American Bar Association
  • ISBN-10: 1627220143
  • ISBN-13: 9781627220149
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781627220149.html
Keywords:
About the Authors xi
Acknowledgments xv
Chapter 1 An Overview of the PCT System
1(18)
1 What the PCT Is
2(1)
2 The PCT Framework
2(5)
2.1 History
2(3)
2.2 Governance
5(2)
3 Statistics
7(1)
4 The PCT Time Frame
8(7)
4.1 The International and National Phases
8(3)
4.2 The PCT Timeline
11(4)
5 Benefits of Using the PCT
15(4)
5.1 Applicants
15(1)
5.2 Patent Offices
16(1)
5.3 Third Parties
17(2)
Chapter 2 PCT Procedures
19(46)
1 Requirements to File under the PCT
19(1)
2 Making an Ineligible Application Eligible: Applicants-of-Convenience
20(1)
3 Where to File an International Application
21(3)
3.1 Choosing the Receiving Office
22(2)
4 Requirements for an International Filing Date
24(1)
5 Completing the Request Form and Options Available at Filing
25(20)
5.1 Getting Started
26(1)
5.2 The Request
26(1)
5.3 The Applicant(s) and Inventor(s)
27(5)
5.4 Agents, Common Representatives, and Address for Correspondence
32(4)
5.5 Designations and Types of Protection
36(2)
5.6 Claiming Priority in a PCT Application
38(1)
5.7 The PCT and U.S. Continuation Practice
39(1)
5.8 The Supplemental Box
40(2)
5.9 Priority Documents
42(2)
5.10 Searching Matters
44(1)
6 Helpful Declarations that Are Available under the PCT
45(8)
6.1 Box No. VIII(i)
47(1)
6.2 Box Nos. VIII(ii) and VIII(iii)
47(3)
6.3 Box No. VIII(iv)
50(1)
6.4 Box VIII(v)
51(2)
7 Sequence Listings
53(4)
7.1 Sequence Listings
53(2)
7.2 Boxes IX and X; Completing the Request
55(2)
8 Biological Deposits
57(1)
9 Fees under the PCT
58(7)
Chapter 3 International Search and Preliminary Examination
65(32)
1 Overview of the System
65(2)
2 Scope of the International Search
67(1)
3 Understanding the ISR and WO
68(2)
4 Selecting an ISA
70(17)
4.1 Factors in Selecting an ISA
71(5)
4.2 ISA Competencies
76(5)
4.3 Effect of ISA Selection on PPH Use
81(1)
4.4 Linguistic Ability
82(1)
4.5 Provision of Cited References
83(1)
4.6 Some Strengths of Each of the ISAs
83(4)
5 The Procedure Following Receipt of the ISR and WO
87(8)
5.1 Amending Your International Application
87(1)
5.2 Article 19 Amendments
88(2)
5.3 Article 34 Amendments and International Preliminary Examination
90(5)
6 Supplementary International Search
95(1)
7 Third-Party Observations
95(2)
Chapter 4 Post-Filing Procedures: Publication, Withdrawals, and Recording Changes
97(14)
1 Publication
98(4)
1.1 The PCT Publication Process
98(3)
1.2 Early Publication
101(1)
1.3 Availability for Licensing
101(1)
2 Withdrawals and Stopping or Postponing Publication
102(6)
2.1 Stopping or Postponing Publication
104(2)
2.2 Withdrawal of Application or Priority Claim after National Phase Entry
106(1)
2.3 Provisional Protection
107(1)
3 Recording Changes: PCT Rule 92bis
108(3)
Chapter 5 Procedural Safeguards: Helpful Options When Things Go Wrong
111(22)
1 Fee and Refund Safeguards
112(2)
2 Publication Safeguards
114(1)
3 Safeguards Relating to Filings Made in Noncompetent Offices
115(2)
4 Restoring Missing Parts or Elements by Incorporation by Reference
117(4)
5 Restoring Priority for Filings Outside the Priority Year
121(3)
6 Correcting or Adding Priority Claims after Filing
124(4)
6.1 Additions or Corrections that Affect the Earliest Priority Claim
126(1)
6.2 Additions or Corrections that Do Not Affect the Earliest Priority Claim
127(1)
6.3 Publication Related to Priority Claims
128(1)
7 Rectification of Obvious Mistakes
128(2)
8 Reinstatement of Rights by National Offices
130(3)
8.1 Review by the National Offices
131(2)
Chapter 6 Entering the National Phase
133(16)
1 Deadlines for Entering the National/Regional Phase
135(5)
1.1 Deadlines for Entering the National/Regional Phase (as of May 2011)
136(2)
1.2 The Four Patent Regions
138(2)
1.3 Patent Grant
140(1)
2 Determining Where to Enter National Phase
140(2)
2.1 Trends in Regional and National Phase Selection
140(2)
3 General Principles Regarding Entering the National Phase
142(5)
3.1 The Translation
143(1)
3.2 The Fees
144(1)
3.3 Foreign Associates
144(1)
3.4 Entering the National Phase Early
145(1)
3.5 Other Requirements
145(2)
4 Missed Deadlines
147(1)
5 Saving Money and Hassle
148(1)
Chapter 7 Entry into the U.S. National Phase
149(22)
1 General Information
149(3)
1.1 National Stage and Bypass
150(2)
2 National Stage
152(10)
2.1 Fees
152(1)
2.2 Oath or Declaration
153(1)
2.3 Documents Required
154(3)
2.4 Pedigree
157(4)
2.5 Filing Dates in a National Stage Application
161(1)
2.6 Restriction Practice in the United States and PCT
161(1)
2.7 Failure to Meet the 30-Month Deadline
162(1)
3 Bypass Application under 35 U.S.C. § 111 (a)
162(9)
3.1 Fees
163(1)
3.2 Oath or Declaration
163(1)
3.3 Documents Required
163(1)
3.4 Pedigree
164(3)
3.5 Restriction Practice
167(1)
3.6 Failure to Meet 30-Month Deadline
168(3)
Chapter 8 Entry into the National Phase in Europe, China, and Elsewhere
171(28)
1 Entering the European Regional Phase
171(5)
1.1 What Is Required
174(1)
1.2 Fees
174(2)
2 Practice upon Entry into the European Regional Phase
176(3)
2.1 Filing of Amendments
176(1)
2.2 Mandatory Response to the IPRP
177(1)
2.3 Opportunity to Respond to Objection that No Meaningful Search Can Be Carried Out
178(1)
2.4 Restriction on Search of Multiple Independent Claims
179(1)
3 EPO Divisional Practice
179(1)
4 Additional Practice Tips
180(3)
4.1 Delaying Entry into Regional Phase
180(1)
4.2 Accelerating Entry into Regional Phase
180(1)
4.3 Making Prosecution More Efficient
180(1)
4.4 Auxiliary Requests
181(1)
4.5 Problem and Solution Approach to Overcome Inventive Step Rejections
181(2)
5 Validation after Grant
183(2)
5.1 Validation Rates
183(1)
5.2 Translations
184(1)
6 National Phase Entry in China
185(6)
6.1 Chinese Emergence
185(1)
6.2 Relationship to Hong Kong
186(1)
6.3 Two Types of Protection Offered
187(1)
6.4 Terminology
188(1)
6.5 Fees
188(1)
6.6 National Phase Entry Form
189(1)
6.7 Deadline for National Phase Entry
189(1)
6.8 Translation
189(1)
6.9 Amendments and Requesting Examination
190(1)
6.10 Assignments
190(1)
7 National Phase Entry in Other Countries
191(1)
8 Other Types of Protection Available via PCT---Utility Models
192(7)
Chapter 9 PCT Strategies and Recommendations
199(44)
1 First Filing Your Application
199(1)
2 Different Laws in Different Countries
200(1)
3 Various Ways to Obtain the Filing of a PCT Application
201(8)
3.1 Using a U.S. Provisional Application as Priority for the PCT Application
201(4)
3.2 Using a Nonprovisional U.S. Application as Priority for the PCT Application
205(2)
3.3 PCT First
207(2)
4 Selecting Countries for National Filing
209(5)
4.1 Factors to Consider in Determining Where to Foreign File
209(1)
4.2 Evaluation of the Invention
210(1)
4.3 Evaluating Countries for Filing
211(1)
4.4 Guidance Tools
212(1)
4.5 Suggestions on Prioritizing Countries
213(1)
5 Drafting a Global Patent Application
214(11)
5.1 The Need for a "Global" Patent Application
215(2)
5.2 General Recommendations for a "Global" Application
217(2)
5.3 Writing a "Global" Patent Application
219(6)
6 Routes to Faster Acceptance: The Patent Prosecution Highway
225(9)
6.1 Purpose of PPH
225(1)
6.2 Three Generations of PPH
225(2)
6.3 Requirements for Use of the PPH
227(2)
6.4 Country Participation
229(1)
6.5 Statistics
230(1)
6.6 Strategic Use of PCT-PPH
231(2)
6.7 Benefits of PPH
233(1)
6.8 Cautions with PPH
233(1)
7 Other Accelerating Programs
234(1)
8 Selecting and Working with Foreign Counsel
235(8)
8.1 Types of Foreign Counsel
235(1)
8.2 Finding a Foreign Counsel
236(1)
8.3 Selection Criteria for Patent Counsel
237(3)
8.4 Working with Foreign Counsel
240(3)
Chapter 10 WIPO Resources
243(12)
1 Priority Document Exchange and Digital Access Services
243(5)
1.1 PDX System
244(1)
1.2 WIPO DAS System
245(3)
2 Use of PDX and WIPO DAS with a PCT Application
248(3)
2.1 When Claiming a U.S. Priority
248(1)
2.2 When Claiming a Foreign Priority
248(3)
3 WIPO Publications
251(3)
3.1 WIPO Internet Resources
252(1)
3.2 PCT Applicant's Guide
252(1)
3.3 PATENTSCOPE
253(1)
3.4 Other PCT Resources Available on the Internet
253(1)
3.5 Really Simple Syndication (RSS) Feeds
254(1)
4 PCT Licensing Feature
254(1)
Chapter 11 Afterword---The Future of the PCT
255(8)
1 Publishing the Written Opinion
256(1)
2 Collaborative Search and Examination
256(1)
3 Making International Search Strategies Available
257(1)
4 ePCT
258(1)
5 PCT-PPH
259(1)
6 Linking the International and National Phases
259(1)
7 Conclusion
260(3)
Appendix. PCT Jargon
1 Glossary of Terms
263(5)
2 Glossary of Abbreviations
268(3)
Index 271
Jay Erstling is of counsel at Patterson Thuente IP, in Minneapolis, Minnesota, and a professor at William Mitchell College of Law in St. Paul, focusing on international IP and PCT matters. Samson Helfgott is director of patents for KattenMuchinRosenman, LLP, in New York City. T. David Reed is a patent agent registered before the USPTO and the Canadian Intellectual Property Office. He lives in Cincinnati, Ohio.